EmbryoTrans Biotech ApS: Financial statements 2017
CVR: 36701676
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,838,431 and a net result of DKK 172,405 compared with DKK 132,445 the year before. That is an increase of 4% compared with the year before. Equity in the 2017 report amounted to DKK 377,402. The solvency ratio was 29.7%.
- Gross Profit
- DKK 1,838,431
- Profit/Loss
- DKK 172,405
- Equity
- DKK 377,402
- Total Assets
- DKK 1,270,171
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Official annual report
Keep an eye on EmbryoTrans Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
EmbryoTrans Biotech ApS has published its annual report for 2016. Gross profit came to DKK 1,767,468, and the net result was DKK 132,445.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees (2018). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.